Shield Therapeutics plc (STX) — Cash Flow Reinvestment Rate
Latest as of June 2020:
0.00x
Shield Therapeutics plc (STX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting GBX2.00K (capex GBX2.00K ) from operating cash flow of GBX2.40 Million. See STX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
GBX2.00K
Capex + Investments
Operating Cash Flow
GBX2.40 Million
GBX
Capital Expenditures
GBX2.00K
GBX
Annual Cash Flow Reinvestment Rate for Shield Therapeutics plc (None–None)
Year-by-year capital reinvestment analysis for Shield Therapeutics plc. See Shield Therapeutics plc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow